Zoetis Inc. (0M3Q.L)

USD 150.31

(0.94%)

Operating Income Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual operating income in 2023 was 3.06 Billion USD , up 6.27% from previous year.
  • Zoetis Inc.'s latest quarterly operating income in 2024 Q3 was 955 Million USD , up 1.55% from previous quarter.
  • Zoetis Inc. reported an annual operating income of 2.88 Billion USD in 2022, up 4.83% from previous year.
  • Zoetis Inc. reported an annual operating income of 2.75 Billion USD in 2021, up 20.41% from previous year.
  • Zoetis Inc. reported a quarterly operating income of 801 Million USD for 2024 Q1, up 12.98% from previous quarter.
  • Zoetis Inc. reported a quarterly operating income of 955 Million USD for 2024 Q3, up 1.55% from previous quarter.

Annual Operating Income Chart of Zoetis Inc. (2023 - 2009)

Historical Annual Operating Income of Zoetis Inc. (2023 - 2009)

Year Operating Income Operating Income Growth
2023 3.06 Billion USD 6.27%
2022 2.88 Billion USD 4.83%
2021 2.75 Billion USD 20.41%
2020 2.28 Billion USD 10.27%
2019 2.07 Billion USD 10.31%
2018 1.88 Billion USD 9.04%
2017 1.72 Billion USD 23.48%
2016 1.39 Billion USD 30.56%
2015 1.07 Billion USD 10.42%
2014 969 Million USD 18.17%
2013 820 Million USD -1.2%
2012 830 Million USD 31.33%
2011 632 Million USD 120.21%
2010 287 Million USD 33.49%
2009 215 Million USD 0.0%

Peer Operating Income Comparison of Zoetis Inc.

Name Operating Income Operating Income Difference
Thermo Fisher Scientific Inc. 6.85 Billion USD 55.256%
Dynavax Technologies Corporation -37.02 Million USD 8388.322%
Illumina, Inc. -1.06 Billion USD 387.091%
IQVIA Holdings Inc. 1.97 Billion USD -55.235%
Biogen Inc. 1.29 Billion USD -136.659%
Iovance Biotherapeutics, Inc. -460.55 Million USD 766.364%
Mettler-Toledo International Inc. 1.08 Billion USD -182.263%
Sarepta Therapeutics, Inc. -267.82 Million USD 1245.902%
Supernus Pharmaceuticals, Inc. -5.26 Million USD 58346.347%
Waters Corporation 817.67 Million USD -275.332%
Perrigo Company plc 151.9 Million USD -1920.408%
uniQure N.V. -282.87 Million USD 1184.947%
Agios Pharmaceuticals, Inc. -391.48 Million USD 883.934%
Amicus Therapeutics, Inc. -73.49 Million USD 4275.851%
Atara Biotherapeutics, Inc. -276 Million USD 1211.932%
bluebird bio, Inc. -244.26 Million USD 1356.438%
Cara Therapeutics, Inc. -121.49 Million USD 2626.03%
Imunon, Inc. -21.03 Million USD 14693.14%
Myriad Genetics, Inc. -123.7 Million USD 2581.002%
Neurocrine Biosciences, Inc. 250.9 Million USD -1123.196%
Nektar Therapeutics -137.42 Million USD 2333.218%
Editas Medicine, Inc. -169.18 Million USD 1914.033%
Verastem, Inc. -92.08 Million USD 3432.827%
Walgreens Boots Alliance, Inc. -14.07 Billion USD 121.803%
Corbus Pharmaceuticals Holdings, Inc. -45.07 Million USD 6908.305%
Heron Therapeutics, Inc. -110.61 Million USD 2874.488%
Unity Biotechnology, Inc. -44.66 Million USD 6970.844%
BioMarin Pharmaceutical Inc. 194.44 Million USD -1478.371%
Sangamo Therapeutics, Inc. -274 Million USD 1220.053%
Evolus, Inc. -49.23 Million USD 6333.624%
Adicet Bio, Inc. -152.03 Million USD 2118.574%
Aclaris Therapeutics, Inc. -97.35 Million USD 3252.316%
Regeneron Pharmaceuticals, Inc. 4.04 Billion USD 24.168%
Esperion Therapeutics, Inc. -155.56 Million USD 2072.834%
FibroGen, Inc. -281.81 Million USD 1189.012%
Agilent Technologies, Inc. 1.35 Billion USD -127.333%
OPKO Health, Inc. -157.02 Million USD 2054.516%
Homology Medicines, Inc. -48.25 Million USD 6459.963%
Geron Corporation -193.94 Million USD 1682.416%
Alnylam Pharmaceuticals, Inc. -282.17 Million USD 1187.623%
Exelixis, Inc. 170.88 Million USD -1695.945%
Viking Therapeutics, Inc. -100.82 Million USD 3143.828%
Anavex Life Sciences Corp. -55.75 Million USD 5604.34%
Intellia Therapeutics, Inc. -515.29 Million USD 695.586%
Axsome Therapeutics, Inc. -231.82 Million USD 1423.843%
Abeona Therapeutics Inc. -48.2 Million USD 6467.22%
Vertex Pharmaceuticals Incorporated 4.3 Billion USD 28.752%
Kala Pharmaceuticals, Inc. -39.15 Million USD 7938.48%
Ionis Pharmaceuticals, Inc. -353.73 Million USD 967.611%
Corcept Therapeutics Incorporated 107.28 Million USD -2760.685%
Halozyme Therapeutics, Inc. 337.57 Million USD -809.134%
Blueprint Medicines Corporation -486.27 Million USD 731.122%
Insmed Incorporated -709.62 Million USD 532.481%
TG Therapeutics, Inc. 20.63 Million USD -14774.231%
Incyte Corporation 620.52 Million USD -394.581%
Emergent BioSolutions Inc. -726.4 Million USD 522.494%